25.96
price down icon0.04%   -0.010
after-market Dopo l'orario di chiusura: 25.90 -0.06 -0.23%
loading

Janux Therapeutics Inc Borsa (JANX) Ultime notizie

pulisher
08:53 AM

Janux Therapeutics Inc: Strategic Advancements and Strong Positioning in Oncology Drive Buy Rating - TipRanks

08:53 AM
pulisher
05:44 AM

Janux Therapeutics Inc. Stock Analysis and ForecastConsistent triple-digit returns - PrintWeekIndia

05:44 AM
pulisher
04:09 AM

Why Intel Stock Is Plummeting Today - The Globe and Mail

04:09 AM
pulisher
09:27 AM

What makes Janux Therapeutics Inc. stock attractive to long term investorsRapid-fire capital growth - jammulinksnews.com

09:27 AM
pulisher
06:27 AM

Janux Therapeutics’ Strategic Expansion and Promising Pipeline Drive Buy Rating - TipRanks

06:27 AM
pulisher
02:05 AM

Janux Therapeutics Faces Trade Policy Challenges: Impact on Operations and Growth - TipRanks

02:05 AM
pulisher
Jul 24, 2025

Innovative Preclinical Programs and Strategic Tumor Activation Drive Buy Rating for Janux Therapeutics - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Janux Therapeutics Inc. stockStrongest growth potential - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Is Janux Therapeutics Inc. stock a growth or value playHigh-profit capital plays - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Janux Therapeutics Inc. stock priceOutstanding capital appreciation - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Janux Therapeutics Highlights Pipeline Progress and Best-in-Class Potential of Novel Bispecific Platform for Autoimmune Diseases at Virtual R&D Day - Business Wire

Jul 24, 2025
pulisher
Jul 24, 2025

Top Stocks Powering the Fourth Industrial Revolution - The Globe and Mail

Jul 24, 2025
pulisher
Jul 23, 2025

Is Janux Therapeutics Inc. a good long term investmentFree Predictions - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Why RTX Stock Is Down Today - The Globe and Mail

Jul 22, 2025
pulisher
Jul 22, 2025

Janux Therapeutics Receives Buy Rating from Leerink Partners Amid Strategic Initiatives and Long-Term Growth Potential - AInvest

Jul 22, 2025
pulisher
Jul 21, 2025

Strategic Initiatives and Long-Term Potential Drive Buy Rating for Janux Therapeutics Inc. - TipRanks

Jul 21, 2025
pulisher
Jul 19, 2025

Teacher Retirement System of Texas Sells 884 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

Jul 19, 2025
pulisher
Jul 19, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Sold by Nisa Investment Advisors LLC - Defense World

Jul 19, 2025
pulisher
Jul 19, 2025

TransCode Therapeutics (NASDAQ:RNAZ) Upgraded at Wall Street Zen - Defense World

Jul 19, 2025
pulisher
Jul 19, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Receives $91.89 Consensus PT from Analysts - Defense World

Jul 19, 2025
pulisher
Jul 19, 2025

E.W. Scripps (NASDAQ:SSP) Lowered to Sell Rating by Wall Street Zen - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

Janux Therapeutics (JANX) Soars 2.31% on R&D Day Announcement - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Janux Therapeutics to Host Virtual R&D Day on July 24, 2025 - BioSpace

Jul 18, 2025
pulisher
Jul 17, 2025

Janux Therapeutics to Showcase New Preclinical Programs at Virtual R&D Day - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

September 19th Options Now Available For Janux Therapeutics (JANX) - Nasdaq

Jul 17, 2025
pulisher
Jul 15, 2025

How Janux Therapeutics Inc. stock performs during market volatilityExplosive Growth Potential - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Janux Therapeutics Inc. stock attracts strong analyst attentionHigh Potential Stock Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Janux Therapeutics Inc. stock price move sharplyProfessional Stock Screener - Newser

Jul 15, 2025
pulisher
Jul 13, 2025

Raymond James Financial Initiates Coverage on Janux Therapeutics (NASDAQ:JANX) - Defense World

Jul 13, 2025
pulisher
Jul 13, 2025

Argus Initiates Coverage on CoreWeave (NASDAQ:CRWV) - Defense World

Jul 13, 2025
pulisher
Jul 13, 2025

Harrow (NASDAQ:HROW) Coverage Initiated at Cantor Fitzgerald - Defense World

Jul 13, 2025
pulisher
Jul 12, 2025

Allspring Global Investments Holdings LLC Increases Stake in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

Jul 12, 2025
pulisher
Jul 12, 2025

Raymond James initiates Janux Therapeutics stock with Outperform rating By Investing.com - Investing.com Canada

Jul 12, 2025
pulisher
Jul 11, 2025

This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Jul 11, 2025
pulisher
Jul 11, 2025

Raymond James Initiates Janux Therapeutics at Outperform With $65 Price Target - MarketScreener

Jul 11, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):